Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Catatonic dilemma in a 33-year-old woman: a discussion.

Koch A, Reich K, Wielopolski J, Clepce M, Fischer M, Kornhuber J, Thuerauf N.

Case Rep Psychiatry. 2013;2013:542303. doi: 10.1155/2013/542303.

2.

[Acute catatonic syndrome after neuroleptic malignant syndrome].

Benjelloun G, Jehel L, Abgrall G, Pelissolo A, Allilaire J.

Encephale. 2005 Nov-Dec;31(6 Pt 1):705-9. French.

PMID:
16462690
3.

[Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].

Erol A, Putgül G, Sert E, Mete L.

Turk Psikiyatri Derg. 2013 Summer;24(2):140-4. Turkish.

4.

Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.

Komatsu T, Nomura T, Takami H, Sakamoto S, Mizuno K, Sekii H, Hatta K, Sugita M.

Intern Med. 2016;55(19):2893-2897.

5.

A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.

Chiou YJ, Lee Y, Lin CC, Huang TL.

Medicine (Baltimore). 2015 Oct;94(43):e1752. doi: 10.1097/MD.0000000000001752. Review.

6.

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam.

Yacoub A, Francis A.

Neuropsychiatr Dis Treat. 2006 Jun;2(2):235-40.

7.

[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].

Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.

Encephale. 2010 Feb;36(1):46-53. doi: 10.1016/j.encep.2009.01.006. French.

PMID:
20159196
8.

["Catatonic dilemma". Therapy with lorazepam and clozapine].

Lausberg H, Hellweg R.

Nervenarzt. 1998 Sep;69(9):818-22. German.

PMID:
9789276
9.

[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].

Menard ML, Yagoubi F, Drici M, Lavrut T, Askenazy F.

Encephale. 2013 May;39 Suppl 1:S29-35. doi: 10.1016/j.encep.2012.08.007. French.

PMID:
23219595
10.

[Catatonia: resurgence of a concept. A review of the international literature].

Pommepuy N, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):481-92. Review. French.

PMID:
12506260
11.

Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report.

Yeh AW, Lee JW, Cheng TC, Wen JK, Chen WH.

Clin Neuropharmacol. 2004 Sep-Oct;27(5):216-8.

PMID:
15602101
12.

ECT for prolonged catatonia.

Malur C, Pasol E, Francis A.

J ECT. 2001 Mar;17(1):55-9.

PMID:
11281518
13.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Review. French.

PMID:
19081460
14.

Residual catatonic state following neuroleptic malignant syndrome.

Caroff SN, Mann SC, Keck PE Jr, Francis A.

J Clin Psychopharmacol. 2000 Apr;20(2):257-9. Review.

PMID:
10770467
15.

[Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].

Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Casamassima F, Litta A, Mauri M, Cassano GB.

Riv Psichiatr. 2012 Mar-Apr;47(2):178-85. doi: 10.1708/1069.11721. Italian.

PMID:
22622253
16.

[Benzodiazepines and schizophrenia, a review of the literature].

Gaillard R, Ouanas A, Spadone C, Llorca PM, Lôo H, Baylé FJ.

Encephale. 2006 Nov-Dec;32(6 Pt 1):1003-10. Review. French.

PMID:
17372546
17.

Pathogenesis and treatment of neuroleptic malignant syndrome.

Ebadi M, Pfeiffer RF, Murrin LC.

Gen Pharmacol. 1990;21(4):367-86. Review.

PMID:
1974219
18.

Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.

Musselman ME, Browning LA, Parker D Jr, Saely S.

Ann Pharmacother. 2011 Nov;45(11):e61. doi: 10.1345/aph.1Q325.

PMID:
21972252
19.

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Andersson JL, Nomikos GG, Marcus M, Hertel P, Mathé JM, Svensson TH.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct;352(4):374-85.

PMID:
8532065
20.

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.

World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369.

PMID:
19673089

Supplemental Content

Support Center